DAVIS, Calif., Dec. 6, 2018 – Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI), launches TerraConnect, a new global biological soil applied and seed treatment platform delivering growers high performance products as well as a broad range of valuable tools to improve and protect crops. TerraConnect is designed to address the need for more sustainable food production systems, increasing regulatory restrictions and the wellbeing of workers, consumers and beneficial insects.

With estimates that the world’s population will increase from 7 to 10 billion by 2050, farmers need effective and environmentally sustainable solutions that are proven to work. Even with today’s technologies, over 40% of crop production is lost to fungal diseases, nematode and insect infestations. Our proprietary biologicals, microbes, and plant extracts offer broad spectrum control, which can be applied alone or combined with other soil or seed protection products as part of integrated management program; answering the call for high performing sustainable life science solutions.

At AgriThority’s 2018 “Exceed the Seed” symposium, Kevin Hammill, Chief Commercial Officer recently noted, “TerraConnect is a new global platform containing a suite of our soil applied and seed treatment products that help deliver solutions for customers who want strong and consistent performance to tackle the toughest pests and environmental stresses. TerraConnect is a tailored solution that benefits customers and consumers by uniting the power of biology with the performance of chemistry to protect & grow plants and our team is dedicated to working with key strategic partners to spread the benefits of this portfolio throughout the world.”

Since its inception in 2006, MBI has long been known as the pioneering force of bio-based pest management. The company is well positioned to help customers seeking customized solutions in the soil applied and seed protection space. High performing biological solutions offer a new category of differentiated product combinations that directly support the evolving needs of farming. According to MarketsandMarkets February 2018 Top Market Report, the seed treatment market is projected to grow at a CAGR of 10.82% from USD $6.76 Billion in 2017, to reach USD $11.31 Billion by 2022. This is due to the increasing demand for integrated pest management practices to minimize pesticide usage, seed treatment products have been gaining preference for their beneficial characteristics such as the ability to combat early-season diseases and pests and their positive effect on crop yield.

About Marrone Bio Innovations
Marrone Bio Innovations, Inc. (NASDAQ: MBII) strives to lead the movement to more sustainable world through the discovery, development and sale of innovative biological products for crop protection, plant health and waterway systems treatment. MBI has screened over 18,000 microorganisms and 350 plant extracts, leveraging its in-depth knowledge of plant and soil microbiomes enhanced by advanced molecular technologies to rapidly develop seven effective and environmentally responsible pest management products to help customers operate more sustainably while uniquely improving plant health and increasing crop yields. Supported by a robust portfolio of over 400 issued and pending patents around its superior natural product chemistry, MBI’s currently available commercial products are Regalia®, Grandevo®, Venerate®, Majestene®, Haven®, Stargus®, Amplitude™, Zelto® and Zequanox®. TerraConnect™ is MBI’s new seed treatment & soil applied platform.

Marrone Bio Innovations is dedicated to pioneering smart biopesticide and plant health solutions that support a better tomorrow for farmers, turf managers and consumers around the globe. Learn more about Marrone Bio Innovations at marronebio.com.
Follow us on Social Media:

Marrone Bio Innovations Forward Looking Statements
This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations and plans, including assumptions underlying such statements, are forward-looking statements, and should not be relied upon as representing MBI’s views as of any subsequent date. Examples of such statements include the potential of the TerraConnect platform to drive sales, provide market projections, and realize the potential benefits of our products. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond the Company’s control, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including weather, regulatory and other factors affecting demand for the MBI’s products, any difficulty in marketing MBI’s products in its target markets, competition in the market for pest management products, lack of understanding of bio-based pest management products by customers and growers. Additional information that could lead to material changes in MBI’s performance is contained in its filings with the SEC. MBI is under no obligation to, and expressly disclaims any responsibility to, update or alter forward-looking statements contained in this release, whether as a result of current information, future events or otherwise.

Ag Trade Commercial Inquires:
Alicia Gillman
Director, Communications
Marrone Bio Innovations
O: (480) 889-4219
E-Mail: AGillman@MarroneBio.com

MBI Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449